Cyclacel Pharmaceuticals Inc.
13F holders, Q4 2024 (December 31)1holders
$7.29avg. 13F price*
At the end of Q4 2024, 1 institutions reported holding Cyclacel Pharmaceuticals Inc. in their 13F filings. The largest holder was VSM Wealth Advisory, LLC ($36K).
- Company
- Cyclacel Pharmaceuticals Inc.
- CUSIP
- 23254L603
- Latest filing quarter
- Q4 2024
Total Exit/New Position Q4 2024
No earlier quarter to compare with.
Ownership 1 holders
| VSM Wealth Advisory, LLC | 0.01% | — | 4,935 | $36K |
"% of holder's portfolio" is CYCLACEL PHARMACEUTICALS INC's weight in each manager's 13F, not the share of Cyclacel Pharmaceuticals Inc. the manager owns.